Dmg Group, LLC Sarepta Therapeutics, Inc. Transaction History

Dmg Group, LLC

$121 Million
Q3 2024

A detailed history of Dmg Group, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Dmg Group, LLC holds 3,261 shares of SRPT stock, worth $340,904. This represents 0.34% of its overall portfolio holdings.

Number of Shares

3,261

Previous 3,397 4.0%

Holding current value

$340,904

Previous $536,000 24.07%

% of portfolio

0.34%

Previous 0.46%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$124.33 - $156.75 $16,908 - $21,318	-136 Reduced 4.0%	3,261 $407,000
Q2 2024 Jul 16, 2024	SELL	$113.33 - $163.85 $35,585 - $51,448	-314 Reduced 8.46%	3,397 $536,000
Q1 2024 Apr 19, 2024	SELL	$93.7 - $141.53 $7,683 - $11,605	-82 Reduced 2.16%	3,711 $480,000
Q4 2023 Jan 10, 2024	BUY	$67.31 - $124.76 $33,385 - $61,880	496 Added 15.04%	3,793 $365,000
Q3 2023 Oct 26, 2023	BUY	$102.5 - $123.59 $9,532 - $11,493	93 Added 2.9%	3,297 $399,000
Q2 2023 Jul 13, 2023	SELL	$106.4 - $157.19 $2,660 - $3,929	-25 Reduced 0.77%	3,204 $366,000
Q1 2023 Apr 24, 2023	BUY	$117.53 - $155.99 $3,996 - $5,303	34 Added 1.06%	3,229 $444,000
Q4 2022 Feb 06, 2023	BUY	$100.86 - $132.13 $19,062 - $24,972	189 Added 6.29%	3,195 $399,000
Q3 2022 Oct 27, 2022	BUY	$75.71 - $119.24 $18,851 - $29,690	249 Added 9.03%	3,006 $330,000
Q2 2022 Aug 09, 2022	BUY	$62.69 - $88.44 $7,021 - $9,905	112 Added 4.23%	2,757 $209,000
Q1 2022 Apr 25, 2022	BUY	$63.15 - $90.42 $167,031 - $239,160	2,645 New	2,645 $202,000

Others Institutions Holding SRPT

# of Institutions

532

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.15B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.

Account